For Magda Szubanski, reaching remission after months of gruelling treatment should have been a moment of uncomplicated relief.
Instead, the Australian comedy and acting icon has revealed the deeply painful reality she continues to live with: the rare blood cancer she has been battling is considered incurable, and she has been told that a relapse is highly likely.
Appearing on 60 Minutes in her first major interview since revealing her diagnosis, the 65-year-old became visibly emotional as she spoke with host Tracy Grimshaw about what it means to know that the illness may return.
“It’s almost sure that it will come back,” Szubanski said. “And it’s a question of when and then how bad.”
Her words offered a sobering insight into life beyond remission — and the very different way she now understands time.

“It’s not abstract” anymore
Szubanski explained that living with the possibility of cancer returning has changed her awareness of death.
For someone whose illness is currently in remission, the threat is no longer something distant or theoretical.
“It is just a different state of consciousness,” she said. “It’s a different awareness of death. It’s not abstract.”
She described the feeling as having a “sword of Damocles” hanging over her, acknowledging that there is an uncertainty she cannot simply put out of her mind.
Yet she also made clear that she is hoping for more time.
Discussing the median survival figure associated with her illness, Szubanski said it was around eight-and-a-half years.
“So, I could go less, or I could go more,” she said, adding that she was “pitching for more”.
That figure is a statistical median, rather than a prediction of how long Szubanski personally has left. Her doctors cannot determine an exact lifespan from that number alone.

The diagnosis that changed everything
Szubanski revealed in May 2025 that she had been diagnosed with stage 4 mantle cell lymphoma, a rare and aggressive type of blood cancer.
At the time, she appeared in a video with her head shaved, preparing for intensive treatment.
She described the diagnosis as “very rare, very aggressive, very serious” and acknowledged how confronting the situation was.
But alongside the fear, she spoke about the people surrounding her and the quality of medical care she was receiving in Melbourne.
She began the Nordic protocol, an intensive treatment approach used for mantle cell lymphoma.
Mantle cell lymphoma affects B cells within the lymphatic system and is a subtype of non-Hodgkin lymphoma. Relapses are common, although treatment and outcomes vary considerably between individuals.
The remission that brought relief — but not certainty
In February 2026, Szubanski shared what appeared at first to be an enormous turning point.
She announced that she had completed chemotherapy and was in remission.
“Phew! Big relief,” she said at the time, while making an important distinction: remission was not the same as a cure.
She expressed hope that the cancer would remain at bay for a long time and thanked the people who had supported her throughout the ordeal.
“I felt so loved up and cared for,” she said, describing the support as something that had helped her emotionally and, she believed, physically as well.
Months later, her latest interview has revealed just how complicated that relief remains.

“It was freaking hard”
Looking back on chemotherapy, Szubanski did not attempt to soften what she endured.
She compared the physical impact of treatment to a “multi-car pile-up”, describing how severely it affected her immune system.
“It completely annihilates your immune system,” she said.
“It was freaking hard, but when I say it was doable, it was.”
Her treatment produced encouraging results, but she understands that those results can change.
That uncertainty is now part of her everyday life.
The frightening signs that came before the diagnosis
Szubanski also recalled how unwell she felt before doctors discovered the cancer.
She described a period in which something simply did not feel right.
At night, she experienced disturbing dreams that would wake her suddenly, with what she described as a voice in her dreams telling her: “You’re dying, you’re dying.”
Looking back, she knew those experiences had been telling her that something was wrong.
Her diagnosis ultimately revealed the seriousness of what was happening inside her body.
A different way of looking at time
The most poignant part of Szubanski’s latest interview may be the way she now speaks about the time ahead.
Rather than presenting herself as defeated, she appears determined to make whatever time she has meaningful.
She has spoken openly about wanting to share experiences that might help other people, particularly because she does not know how long she will have to do so.
That perspective has also encouraged her to speak about deeply personal parts of her past that she had never previously discussed publicly.
Her decision to tell those stories appears connected to the same realisation she has reached through her cancer journey: time is precious, and silence can carry its own weight.
Gratitude amid an uncertain future
Despite the painful prognosis, Szubanski has continued to express profound gratitude for her medical team and Australia’s healthcare system.
She has repeatedly praised the care she received in Melbourne, describing the Australian medical community as among the best in the world.
And throughout the darkest moments, her characteristic humour has remained part of the way she faces what lies ahead.
Her story is therefore not simply about an incurable cancer or a statistical survival figure.
It is about the strange space between relief and fear — being well enough to celebrate remission while knowing that remission does not necessarily mean the end of the battle.
For Magda Szubanski, the future remains uncertain.
But for now, she is here, speaking openly, making people laugh when she can, and choosing to use her voice while she has it.